Welcome to Psychiatryai.com: Latest Evidence - RAISR4D

Beyond Enthusiasm: Ayahuasca and the Future of Depression Research

AI Summary
  • Prioritise rigorous, placebo-controlled clinical trials to establish ayahuasca's antidepressant efficacy beyond anecdote.
  • Investigate biological and psychological mechanisms, standardise dosing, and account for set and setting influences on outcomes.
  • Address safety, adverse effects, long-term outcomes, ethical concerns, cultural context, and regulatory frameworks for clinical implementation.
Summarise with AI (MRCPsych/FRANZCP)

Braz J Psychiatry. 2026 Jul 7. doi: 10.47626/1516-4446-2026-5035. Online ahead of print.

NO ABSTRACT

PMID:42413001 | DOI:10.47626/1516-4446-2026-5035

Document this CPD

Share Evidence Blueprint

QR Code

Search Google Scholar

Save as PDF

close chatgpt icon
ChatGPT

Enter your request.

Psychiatry AI: Real-Time AI Scoping Review